Revealing the Latest Updates in the TGF-β for Immuno-Oncology Pipeline
Time: 8:30 am
day: Day One
Details:
- Discussing the cell types that the compound has a mechanism of action on
- What can a TGF-β inhibitor do relative to other targeted therapies or checkpoint inhibitors?
- Looking to the future for TGF-β drug development